Rx Processing Corp.(OTC: RXPC) Revenues Year Ending 12/31/04: $822,130 (Unaudited: Source: 15c-211, 5/4/05) Market Leader in Providing Prescription Drugs, Lab Tests and Drug Tests to U.S. Citizens, Corporations, Unions, and Members Through FDA-Approved Patient Service Centers for Their Lab Testing and Licensed Pharmacies in the United States and Canada. (Source: News 5/10/05) Current Price: .10 Target Price: .93 Rating: Highly recommended buy INVESTMENT HIGHLIGHTS: (Source: Recent News Releases) 1)Rx Processing Corp. Announces Strategic Partnership Agreement with Financial Services International, Inc.- This alliance is anticipated to increase sales of the Rx Processing's discounted prescription drugs and lab services within large groups through the added benefit of FSI's Stored Value Cards for payroll and payment services as well as improve the Company's member ID card distribution process essential to servicing corporate clients. 2)Rx Processing Corp Secures Five-Year Contract with The Health Advantage- The contract is a five-year agreement establishing Rx Processing's ``Lab Pass Network'' as the exclusive provider of discounted diagnostic testing to The Health Advantage's large corporate clients, representing millions of individuals. ABOUT RXPC (Source: News 3/29/05) Rx Processing is rapidly becoming a market leader in providing prescription drugs, lab tests and drug tests to U.S. citizens, corporations, unions, and members through FDA-approved patient service centers for their Lab testing and licensed pharmacies in the United States and Canada. The Company provides access to more than 1,500 approved brand name and generic medications and provides access to over 1,000 diagnostic tests including: heart disease risk assessment, cancer detection and several other wellness tests and early detection diagnostics ready for distribution an service in the U.S. market through its company-owned and operated storefront locations and affiliated storefronts with access to 3,000 FDA-approved patient service centers. By utilizing Rx Processing, U.S. citizens can save up to 84% on their daily prescriptions up to 50% on their lab testing and drugs screening. Please Watch This One Trade. These little stocks can surprise in a big way sometimes.... _______________________________ Information within this email contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements."Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as "projects", "foresee", "expects", "will," "anticipates," "estimates," "believes," "understands" or that by statements indicating certain actions "may," "could," or "might" occur. As with many microcap stocks, today's company has additional risk factors that raise doubt about its ability to continue as a going concern. Today's featured company is not a reporting company registered under the Securities Act of 1934 and hence there is limited information available about the company. Other factors include a limited operating history,a nominal cash position, default on a loan, a lawsuit that could effect the company's revenues and profitability, an accumulated deficit since its inception and a reliance on loans from shareholders to pay expenses. The company is going to need financing. If that financing does not occur,the company may not be able to continue as a going concern in which case you could lose your entire investment. Other risks and uncertainties include, but are not limited to, the ability of the Company to complete its business plan,reliance on key personnel, market conditions, the general acceptance of the Company's products and technologies, competitive factors, timing, and other risks associated with their business. The publisher of this newsletter does not represent that the information contained in this message states all material facts or does not omit a material fact necessary to make the statements therein not misleading.All information provided within this email pertaining to investing, stocks, securities must be understood as information provided and not investment advice. The publisher of this newsletter advises all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in stocks featured within this email. None of the material within this report shall be construed as any kind of investment advice or solicitation.Many of these companies are on the verge of bankruptcy. You can lose all your money by investing in this stock. The publisher of this newsletter is not a registered investment advisor. Subscribers should not view information herein as legal, tax, accounting or investment advice. Any reference to past performance(s) of companies are specially selected to be referenced based on the favorable performance of these companies. You would need perfect timing to acheive the results in the examples given. There can be no assurance of that happening. Remember, as always, past performance is never indicative of future results and a thorough due diligence effort, including a review of a company's filings when available, should be completed prior to investing. In compliance with the Securities Act of 1933, Section17(b), The publisher of this newsletter is contracted to receive ten thousand dollars from a third party, not an officer, director or affiliate shareholder for the circulation of this report. Be aware of an inherent conflict of interest resulting from such compensation due to the fact that this is a paid advertisement and is not without bias.The party that paid us has a position in the stock they will sell at anytime without notice. This could have a negative impact on the price of the stock, causing you to lose money. All factual information in this report was gathered from public sources, including but not limited to Company Websites and Company Press Releases. The publisher of this newsletter believes this information to be reliable but can make no guarantee as to its accuracy or completeness. Use of the material within this email constitutes your acceptance of these terms. i10IXD